Presently, Emily Hill occupies the position of Chief Financial Officer at PTC Therapeutics, Inc.

Ms. Hill previously held the position of Associate-Biotech Equity Research at Summer Street Capital Partners LLC, Senior Manager-Investor Relations at Genzyme Corp. and Head-Investor Relations Contact at Warner Chilcott Plc.

Ms. Hill received an undergraduate degree from Hamilton College (New York), an undergraduate degree from Tufts University School of Medicine and an MBA from Fordham Gabelli School of Business.